The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram.
Abstract
The aim of the study was to investigate the efficacy and safety of the selective serotonin reuptake inhibitor citalopram in treating poststroke depression, since available treatments are usually poorly tolerated. A 6-week double-blind, placebo-controlled trial was undertaken. Diagnosis and outcome were determined using the Hamilton Depression Scale, and unwanted effects were measured using the UKU side effect rating scale. Sixty-six consecutive depressed patients from an unselected population of 285 stroke patients aged 25 to 80 years entered the trial 2 to 52 weeks after stroke. They were assigned to equally sized treatment and placebo groups. The initial level of depression was comparable in the two groups (mean baseline Hamilton Depression scores, 19.4 and 18.9, respectively). Demographic parameters were also comparable in the two groups. Significantly greater improvement was seen in patients treated with citalopram (10 to 40 mg/d) for 3 and 6 weeks, both when including all patients (intention-to-treat analysis, P < .05) and excluding patients who dropped out during the first 3 weeks (efficacy analysis, P < .005). Half of the 28 patients who entered the trial 2 to 6 weeks after stroke recovered within 1 month, independent of the treatment given. This indicates a high degree of spontaneous recovery in the early phase after stroke. In contrast, recovery was infrequent in placebo group patients who became depressed 7 weeks or more after stroke. No serious side effects related to the treatment were detected; those present were mild and usually transient. This trial demonstrates that the selective serotonin reuptake inhibitor citalopram offers an advantageous new treatment of poststroke depression that is both safe and effective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Functional evaluation : Barthel index
Mahonery, F. I. (1965) · Medical Entomology and Zoology · Cited by 12,762
The assessment of aphasia and related disorders
Goodglass, H., & Kaplan, E. (1972) · Medical Entomology and Zoology · Cited by 3,258
Lingjærde, O., Ahlfors, U. G., Bech, P., Dencker, S. J., & Elgen, K. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb10566.x · Cited by 1,705
The Diagnosis of Depressive Syndromes and the Prediction of E.C.T. Response
Carney, M. W. P., Roth, M., & Garside, R. F. (1965) · British Journal of Psychiatry · doi:10.1192/bjp.111.477.659 · Cited by 936
AN ACTIVITIES INDEX FOR USE WITH STROKE PATIENTS
HOLBROOK, M., & SKILBECK, C. E. (1983) · Age and Ageing · doi:10.1093/ageing/12.2.166 · Cited by 661
Post-stroke depressive disorders: a follow-up study of 103 patients.
Robinson, R. G., & Price, T. R. (1982) · Stroke · doi:10.1161/01.str.13.5.635 · Cited by 564
NORTRIPTYLINE TREATMENT OF POST-STROKE DEPRESSION: A DOUBLE-BLIND STUDY
Lipsey, J., Pearlson, G., Robinson, R., Rao, K., & Price, T. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90356-8 · Cited by 539
Skilbeck, C. E., Wade, D. T., Hewer, R. L., & Wood, V. A. (1983) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.46.1.5 · Cited by 510
Bech, P., Kastrup, M., & Rafaelsen, O. J. (1986) · PubMed · Cited by 467
Cited by
Post-Stroke Depression: A Review
Robinson, R. G., & Jorge, R. E. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15030363 · Cited by 1,125
Mood disorders in the medically ill: scientific review and recommendations
Evans, D. L., Charney, D. S., Lewis, L., Golden, R. N., Gorman, J. M., Krishnan, K. R. R., Nemeroff, C. B., Bremner, J. D., Carney, R. M., Coyne, J. C., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.001 · Cited by 1,071
Bauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632
“Citalopram was more effective compared to placebo in a 6-week post-stroke study (Andersen et al. 1994).”
MethodPost stroke depression: epidemiology, pathophysiology, and biological treatment
Whyte, E. M., & Mulsant, B. H. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01424-5 · Cited by 488
Incidence of central post-stroke pain
Andersen, G., Vestergaard, K., Ingeman-Nielsen, M., & Jensen, T. S. (1995) · Pain · doi:10.1016/0304-3959(94)00144-4 · Cited by 465
Self-citationThe Sunnybrook Stroke Study: A Prospective Study of Depressive Symptoms and Functional Outcome
Herrmann, N., Black, S. E., Lawrence, J., Szekely, C., & Szalai, J. P. (1998) · Stroke · doi:10.1161/01.str.29.3.618 · Cited by 451
An Evidence-Based Review of Stroke Rehabilitation
Teasell, R. W., Foley, N. C., Bhogal, S. K., & Speechley, M. R. (2003) · Topics in Stroke Rehabilitation · doi:10.1310/8yna-1yhk-ymhb-xte1 · Cited by 433
The advances of post-stroke depression: 2021 update
Guo, J., Wang, J., Sun, W., & Liu, X. (2022) · Journal of Neurology · doi:10.1007/s00415-021-10597-4 · Cited by 400
Interventions for treating depression after stroke
Hackett, M. L., Anderson, C. S., House, A., & Xia, J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003437.pub3 · Cited by 387
Robinson, R. G., Schultz, S. K., Castillo, C., Kopel, T., Kosier, J. T., Newman, R. M., Curdue, K., Petracca, G., & Starkstein, S. E. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.3.351 · Cited by 384
Neuropsychiatric outcomes of stroke
Hackett, M. L., Köhler, S., O'Brien, J. T., & Mead, G. E. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70016-x · Cited by 351
Dam, M., Tonin, P., De Boni, A., Pizzolato, G., Casson, S., Ermani, M., Freo, U., Piron, L., & Battistin, L. (1996) · Stroke · doi:10.1161/01.str.27.7.1211 · Cited by 347
Bauer, M., Whybrow, P. C., Angst, J., Versiani, M., Möller, H.-J., & WFSBP Task Force on Treatment Guide (2002) · The World Journal of Biological Psychiatry · doi:10.3109/15622970209150599 · Cited by 346
Poststroke Depression: A Review
Robinson, R. G., & Spalletta, G. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005500602 · Cited by 315
Chemerinski, E., & Robinson, R. G. (2000) · Psychosomatics · doi:10.1016/s0033-3182(00)71168-6 · Cited by 304
Holloway, R. G., Arnold, R. M., Creutzfeldt, C. J., Lewis, E. F., Lutz, B. J., McCann, R. M., Rabinstein, A. A., Saposnik, G., Sheth, K. N., Zahuranec, D. B., et al. (2014) · Stroke · doi:10.1161/str.0000000000000015 · Cited by 286
Depression after Stroke and Risk of Mortality: A Systematic Review and Meta-Analysis
Bartoli, F., Lillia, N., Lax, A., Crocamo, C., Mantero, V., Carrà, G., Agostoni, E., & Clerici, M. (2013) · Stroke Research and Treatment · doi:10.1155/2013/862978 · Cited by 273
Fluoxetine in Early Poststroke Depression: A Double-Blind Placebo-Controlled Study
Wiart, L., Petit, H., Joseph, P. A., Mazaux, J. M., & Barat, M. (2000) · Stroke · doi:10.1161/01.str.31.8.1829 · Cited by 261
Risk factors for post‐stroke depression
Andersen, G., Vestergaard, K., Ingemann‐Nielsen, M., & Lauritzen, L. (1995) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1995.tb09567.x · Cited by 257
Self-citationRamasubbu, R., Taylor, V. H., Samaan, Z., Sockalingham, S., Li, M., Patten, S., Rodin, G., Schaffer, A., Beaulieu, S., & McIntyre, R. S. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400110 · Cited by 206
Poststroke depression: An examination of the literature
Gordon, W. A., & Hibbard, M. R. (1997) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/s0003-9993(97)90433-0 · Cited by 171
The relevance of emotional and psychosocial factors in aphasia to rehabilitation
Code, C., & Herrmann, M. (2003) · Neuropsychological Rehabilitation · doi:10.1080/09602010244000291 · Cited by 150
“However, trials have shown, for instance, that the SSRI citalopram is well tolerated and has only mild side effects (Andersen et al., 1994).”
ResultAcler, M., Robol, E., Fiaschi, A., & Manganotti, P. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5093-7 · Cited by 139
Price, A., Rayner, L., Okon-Rocha, E., Evans, A., Valsraj, K., Higginson, I. J., & Hotopf, M. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.230862 · Cited by 90
The Emotional Impact of Aphasia
Code, C., Hemsley, G., & Herrmann, M. (1999) · Seminars in Speech and Language · doi:10.1055/s-2008-1064006 · Cited by 72
The pharmacological management of depression
Kupfer, D. J. (2005) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2005.7.3/dkupfer · Cited by 69
Emerging strategies in the treatment of poststroke depression and psychiatric distress in patients
Capaldi II, V. F., & Wynn (2010) · Psychology Research and Behavior Management · doi:10.2147/prbm.s10035 · Cited by 25
Metadata
- Authors
- Andersen, G., Vestergaard, K., & Lauritzen, L.
- Venue
- Stroke
- Published
- 1994-06
- Volume
- 25
- Issue
- 6
- Pages
- 1099-1104
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2152762049
- Cited by
- 378
- References
- 34
- FWCI
- 16.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.